Clinical Trials · NCT01863680

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

Name: Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Merck KGaA, Darmstadt, Germany
Enrollment: 178
Start date: Jul 2013
Locations: 5 sites, Japan
Primary endpoint: Clinical Pregnancy Rate Per Embryo Transfer

View Gonadorelin compound reference